1.
Gold LS, Del Rosso JQ, Kircik L, Bhatia ND, Hooper D, Nahm W, Stuart I. Open-Label Extension Study Evaluating the Long-Term Safety, Efficacy, and Tolerability of FMX103 1.5% Topical Minocycline Foam in the Treatment of Moderate-to-Severe Facial Papulopustular Rosacea. J of Skin [Internet]. 2020Sep.2 [cited 2022Jul.3];4(5):s54. Available from: https://jofskin.org/index.php/skin/article/view/998